Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Br J Haematol. 2015 Jun 30;171(1):91–99. doi: 10.1111/bjh.13529

Figure 5.

Figure 5

Proposed bone marrow evaluation algorithm for myelodysplastic syndromes. Proposed bone marrow evaluation algorithm for patients with de novo myelodysplastic syndromes incorporating fibrosis assessment, TP53 immunohistochemistry (IHC), and TP53 mutation analysis.